Nanjing Pharmaceutical Factory Co., Ltd. (NPF) was established in 1935. Following this, the organization carried out relocations of its facilities, relocating the finished dosage plant to Nanjing Xingang Industrial Park in 2001 and the API plant to Nanjing Chemical Industrial Park in 2003. Over time, NPF has evolved into a sizable and integrated producer with robust research and development capabilities for API, finished dosage, and pharmaceutical intermediates. The API facility spans 120,000 square meters and comprises 6 specialized and versatile workshops, along with extensive land for potential expansion. Manufacturing and quality systems are operated in compliance with cGMP regulations. Nanjing Well Pharmaceutical Group Co., Ltd. was formed in 2000 through the comprehensive conversion of the original Nanjing Well Chemical Co., Ltd. Since its inception, the firm has concentrated on the research and development, manufacturing, and marketing of pharmaceutical excipients and synthetic lubricating base oils, supplying customers with advanced new products such as high-safety and multifunctional pharmaceutical excipients and synthetic lubricating base oils with outstanding performance. The company's pharmaceutical excipient products are utilized in various pharmaceutical dosage forms, including injections, oral administration, and external applications.
Products & Services
Clevidipine
Clevidipine butyrate non-sterile active pharmaceutical ingredient
Degarelix Acetate
Levamisole
Sites
Nanjing Asia-East Sunrise Pharmaceutical
Country
People's Republic of ChinaCity
Nanjing